Ignite Creation Date:
2024-05-06 @ 3:33 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02319369
Status:
TERMINATED
Last Update Posted:
2021-10-11
First Post:
2014-12-15
Brief Title:
Safety Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine AZA in Acute Myelogenous Leukemia AML or High-Risk Myelodysplastic Syndrome MDS
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Organization Data
Organization:
Daiichi Sankyo
Class:
INDUSTRY
Study ID:
DS3032-A-U102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daiichi Sankyo
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None